자가면역질환 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Autoimmune Disease Diagnostics Market size is expected to reach USD 15.30 Billion in 2034 from USD 6.74 Billion (2025) growing at a CAGR of 9.54% during 2026-2034.

The autoimmune disease diagnostics market is poised for significant growth, driven by the increasing prevalence of autoimmune disorders and advancements in diagnostic technologies. As awareness of autoimmune diseases rises, healthcare providers are increasingly focusing on early detection and accurate diagnosis to improve patient outcomes. Innovations in laboratory techniques, such as enzyme-linked immunosorbent assays (ELISA), multiplex assays, and next-generation sequencing, are enhancing the sensitivity and specificity of diagnostic tests. These advancements enable clinicians to identify a wide range of autoimmune conditions, including rheumatoid arthritis, lupus, and multiple sclerosis, facilitating timely and effective treatment strategies.

Moreover, the growing emphasis on personalized medicine is influencing the autoimmune disease diagnostics market. Tailoring treatment plans based on individual patient profiles and genetic markers is becoming increasingly feasible, allowing for more effective and targeted interventions. The integration of artificial intelligence and machine learning in diagnostic processes is also gaining traction, as these technologies can analyze complex data sets to identify patterns and predict disease progression. This shift towards data-driven diagnostics is expected to enhance the accuracy of autoimmune disease detection and improve patient management.

Additionally, the rise of point-of-care testing is transforming the landscape of autoimmune diagnostics. Rapid and convenient testing options are becoming essential in clinical settings, enabling healthcare providers to make informed decisions quickly. This trend is particularly relevant in remote and underserved areas, where access to specialized diagnostic facilities may be limited. In summary, the autoimmune disease diagnostics market is set for robust growth, characterized by technological innovation, personalized approaches, and a commitment to improving patient care in the face of complex autoimmune conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables & Assay Kits
• Instruments

By Test Type

• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Test
• Other

By Disease

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• SjAfA¶gren's Syndrome
• Thyroiditis
• Scleroderma
• Other

By End User

• Clinical Laboratories
• Hospitals
• Other

COMPANIES PROFILED

• Thermo Fisher Scientific, Siemens, Abbott, Danaher, BioRad Laboratories, Grifols, Trinity Biotech, Werfen, HYCOR Biomedical, EUROIMMUN AG, Oncimmune, HTG Molecular Diagnostics, Seramun Diagnostica GmbH, Exagen Inc, Cambridge Life Sciences Limited

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables & Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Routine Laboratory Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inflammatory Markers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Autoantibodies & Immunologic Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY DISEASE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease
• 6.2. Rheumatoid Arthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Systemic Lupus Erythematosus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. SjAfA¶gren's Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Thyroiditis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Scleroderma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Test Type
  • 8.2.3 By Disease
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Test Type
  • 8.3.3 By Disease
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Test Type
  • 8.4.3 By Disease
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Test Type
  • 8.5.3 By Disease
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Test Type
  • 8.6.3 By Disease
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific
  • 10.2.2 Siemens
  • 10.2.3 Abbott
  • 10.2.4 Danaher
  • 10.2.5 Bio-Rad Laboratories
  • 10.2.6 Grifols
  • 10.2.7 Trinity Biotech
  • 10.2.8 Werfen
  • 10.2.9 HYCOR Biomedical
  • 10.2.10 EUROIMMUN AG
  • 10.2.11 Oncimmune
  • 10.2.12 HTG Molecular Diagnostics
  • 10.2.13 Seramun Diagnostica GmbH
  • 10.2.14 Exagen Inc
  • 10.2.15 Cambridge Life Sciences Limited